Trial
NCT05549921
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Condition
Soft Tissue Sarcoma
Intervention
NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
Why stopped
The study was terminated due to initiation of a new clinical trial with an updated study design.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-12